fulvestrant has been researched along with valproic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Hyttinen, JM; Kaarniranta, K; Kyrylenko, S; Ojala, J; Salminen, A; Suuronen, T; Thornell, A | 1 |
1 review(s) available for fulvestrant and valproic acid
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for fulvestrant and valproic acid
| Article | Year |
|---|---|
Regulation of ER alpha signaling pathway in neuronal HN10 cells: role of protein acetylation and Hsp90.
Topics: Acetylation; Animals; Benzoquinones; Cell Line; Dactinomycin; Dehydroepiandrosterone; Diethylstilbestrol; Enzyme Inhibitors; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Estrogens; Estrogens, Non-Steroidal; Fulvestrant; Genes, Reporter; Histone Deacetylase Inhibitors; Histone Deacetylases; HSP90 Heat-Shock Proteins; Humans; Hydroxamic Acids; Lactams, Macrocyclic; Neurons; Protein Synthesis Inhibitors; Selective Estrogen Receptor Modulators; Signal Transduction; Sirtuin 2; Sirtuins; Transcriptional Activation; Valproic Acid | 2008 |